Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study - Concepedia

Concepedia

Publication | Open Access

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

DOI Full Paper Access

10

Citations

18

References

2020

Year

Marc Vervloet, Ioannis Boletis, Ángel L.M. de Francisco, Philip A. Kalra, Markus Ketteler, Piergiorgio Messa, Manuela Stauss‐Grabo, Anja Derlet, Sebastian Walpen, Amandine Perrin,

Clinical Kidney Journal

Abstract

SFOH has a favourable safety and tolerability profile in a real-world setting, consistent with results of the Phase 3 study. Moreover, SFOH improved serum phosphorus control with a low daily pill burden.

References

	Year	Citations

Page 1